Jo Anna Witter, MD | |
358 S 10, David City, NE 68632-2116 | |
(402) 367-3322 | |
(402) 367-3311 |
Full Name | Jo Anna Witter |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 33 Years |
Location | 358 S 10, David City, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942239421 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 18840 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Midwest Home Health, Inc. Dba Angels Care Home Hea | Omaha, NE | Home health agency |
St. Croix Hospice, Llc | Omaha, NE | Hospice |
Butler County Health Care Center | David city, NE | Hospital |
The Nebraska Medical Center | Omaha, NE | Hospital |
Columbus Community Hospital | Columbus, NE | Hospital |
David Place | David city, NE | Nursing home |
Entity Name | Butler County Health Care Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790780237 PECOS PAC ID: 9739281106 Enrollment ID: O20200523000123 |
News Archive
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.
Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the second quarter ended June 30, 2011, an increase of 24 percent when compared to $875.3 million in the second quarter 2010.
The U.S. Food and Drug Administration has awarded a contract to Harvard Pilgrim Health Care Inc. to develop a pilot of the FDA's Sentinel System, which will use automated health care data to evaluate medical product safety.
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Jo Anna Witter, MD 358 S 10th, Po Box 110, David City, NE 68632-2116 Ph: (402) 367-3322 | Jo Anna Witter, MD 358 S 10, David City, NE 68632-2116 Ph: (402) 367-3322 |
News Archive
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.
Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the second quarter ended June 30, 2011, an increase of 24 percent when compared to $875.3 million in the second quarter 2010.
The U.S. Food and Drug Administration has awarded a contract to Harvard Pilgrim Health Care Inc. to develop a pilot of the FDA's Sentinel System, which will use automated health care data to evaluate medical product safety.
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.
› Verified 5 days ago
Joshua Sypal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Mark Vaughn Carlson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Victor James Thoendel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Gerald Walter Luckey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Robert R Rauner, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Dr. Robert Austin Daro, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 |